These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 38321099)

  • 21. The impact of HMG-CoA reductase inhibitors use on the clinical outcomes in critically ill patients with COVID-19: A multicenter, cohort study.
    Al Sulaiman K; Aljuhani O; Korayem GB; Altebainawi AF; Al Harbi S; Al Shaya A; Badreldin HA; Kensara R; Alharthi AF; Alghamdi J; Alawad A; Alotaibi R; Kharbosh A; Al Muqati H; Alhuwahmel A; Almusallam M; Albarrak G; Al Sulaihim I; Alanazi B; Al-Dosari BS; Vishwakarma R; Alsaeedi AS; Al Ghamdi G; Alkofide H; Al-Dorzi HM
    Front Public Health; 2022; 10():877944. PubMed ID: 36033795
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The COVIRL002 Trial-Tocilizumab for management of severe, non-critical COVID-19 infection: A structured summary of a study protocol for a randomised controlled trial.
    Cotter A; Wallace D; McCarthy C; Feeney E; O'Neill L; Stack J; McCarthy G; Hussain R; Alvarez Barco E; Doran P; Mallon P
    Trials; 2020 Sep; 21(1):758. PubMed ID: 32883328
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early dexamethasone use as a protective measure in non-mechanically ventilated critically ill patients with COVID-19: a multicenter, cohort study.
    Al Sulaiman K; Korayem GB; Eljaaly K; Altebainawi AF; Al Harbi O; Badreldin HA; Al Harthi A; Al Yousif G; Vishwakarma R; Albelwi S; Almutairi R; Almousa M; Alghamdi R; Alhubaishi A; Alissa A; Alharbi A; Algarni R; Al Homaid S; Al Qahtani K; Akhani N; Al Atassi A; Al Ghamdi G; Aljuhani O
    Sci Rep; 2022 Jun; 12(1):9766. PubMed ID: 35697822
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The association of interleukin-6 value, interleukin inhibitors, and outcomes of patients with COVID-19 in New York City.
    Maeda T; Obata R; Rizk DO D; Kuno T
    J Med Virol; 2021 Jan; 93(1):463-471. PubMed ID: 32720702
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tocilizumab is associated with reduced delirium and coma in critically ill patients with COVID-19.
    Alkhateeb T; Stollings JL; Sohn I; Liu D; Fleenor LM; Ely EW; Lahiri S
    Sci Rep; 2024 May; 14(1):11738. PubMed ID: 38778074
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dexamethasone versus methylprednisolone for multiple organ dysfunction in COVID-19 critically ill patients: a multicenter propensity score matching study.
    Aljuhani O; Korayem GB; Altebainawi AF; AlMohammady D; Alfahed A; Altebainawi EF; Aldhaeefi M; Badreldin HA; Vishwakarma R; Almutairi FE; Alenazi AA; Alsulaiman T; Alqahtani RA; Al Dhahri F; Aldardeer N; Alenazi AO; Al Harbi S; Kensara R; Alalawi M; Al Sulaiman K
    BMC Infect Dis; 2024 Feb; 24(1):189. PubMed ID: 38350878
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ascorbic acid as an adjunctive therapy in critically ill patients with COVID-19: a propensity score matched study.
    Al Sulaiman K; Aljuhani O; Saleh KB; Badreldin HA; Al Harthi A; Alenazi M; Alharbi A; Algarni R; Al Harbi S; Alhammad AM; Vishwakarma R; Aldekhyl S
    Sci Rep; 2021 Sep; 11(1):17648. PubMed ID: 34480041
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of zinc sulfate as an adjunctive therapy in COVID-19 critically ill patients: a two center propensity-score matched study.
    Al Sulaiman K; Aljuhani O; Al Shaya AI; Kharbosh A; Kensara R; Al Guwairy A; Alharbi A; Algarni R; Al Harbi S; Vishwakarma R; Korayem GB
    Crit Care; 2021 Oct; 25(1):363. PubMed ID: 34663411
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interleukin-6 receptor blockade with subcutaneous tocilizumab improves coagulation activity in patients with COVID-19.
    Di Nisio M; Potere N; Candeloro M; Spacone A; Pieramati L; Ferrandu G; Rizzo G; La Vella M; Di Carlo S; Cibelli D; Parruti G; Levi M; Porreca E
    Eur J Intern Med; 2021 Jan; 83():34-38. PubMed ID: 33162299
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incidence and Clinical Outcomes of New-Onset Atrial Fibrillation in Critically lll Patients with COVID-19: A Multicenter Cohort Study - New-Onset Atrial Fibrillation and COVID-19.
    Kensara R; Aljuhani O; Korayem GB; Alkofide H; Almohareb SN; Alosaimi YS; Altebainawi AF; Bin Saleh K; Andas NA; Harbi SA; Harthi AFA; Ashkan U; Alghamdi R; Badreldin HA; Hafiz A; AlFaifi M; Alqahtani RA; Vishwakarma R; Alenazi AA; Alalawi M; Mahboob R; Alfouzan RA; Al Tuhayni LB; Qahtani NA; Sulaiman KA
    Clin Appl Thromb Hemost; 2023; 29():10760296231156178. PubMed ID: 36789786
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Role of Inhaled Corticosteroids (ICS) in Critically Ill Patients With COVID-19: A Multicenter, Cohort Study.
    Al Sulaiman K; Aljuhani O; Al Aamer K; Al Shaya O; Al Shaya A; Alsaeedi AS; Alhubaishi A; Altebainawi AF; Al Harthi A; Albelwi S; Almutairi R; Alsubaie N; Alsallum A; Korayem GB; Alfahed A; Kensara R; Altebainawi EF; Alenezi RS; Alsulaiman T; Al Enazi H; Vishwakarma R; Al Dabbagh T; Bakhsh U; Al Ghamdi G
    J Intensive Care Med; 2022 Feb; 37(2):248-257. PubMed ID: 34757869
    [No Abstract]   [Full Text] [Related]  

  • 32. Tocilizumab in critically ill COVID-19 patients: An observational study.
    Mushtaq MZ; Mahmood SBZ; Almas A; Ather Wasti S; Ahsan Ali S
    Int Immunopharmacol; 2022 Jan; 102():108384. PubMed ID: 34838490
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outcomes of tocilizumab therapy in severe or critical COVID-19 patients: A retrospective cohort, single-centre study.
    Abdelnaby H; Aboelhassan W; Al-Jarallah M; Rajan R; Dashti R; Zhanna KD; Alsaber AR; Abd El-Aleem A; Ashry I; Abdullah M; Mahmoud Fouad A
    Trop Med Int Health; 2021 Dec; 26(12):1689-1699. PubMed ID: 34601803
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Experience with tocilizumab in severe COVID-19 pneumonia after 80 days of follow-up: A retrospective cohort study.
    Moreno-Pérez O; Andres M; Leon-Ramirez JM; Sánchez-Payá J; Rodríguez JC; Sánchez R; García-Sevila R; Boix V; Gil J; Merino E
    J Autoimmun; 2020 Nov; 114():102523. PubMed ID: 32690352
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Management of Renin-Angiotensin-Aldosterone System blockade in patients admitted to hospital with confirmed coronavirus disease (COVID-19) infection (The McGill RAAS-COVID- 19): A structured summary of a study protocol for a randomized controlled trial.
    Aflaki M; Flannery A; Ferreira JP; Cheng MP; Kronfli N; Marelli A; Zannad F; Brophy J; Afillalo J; Huynh T; Giannetti N; Bessissow A; Ezekowitz JA; Lopes RD; Ambrosy AP; Craig M; Sharma A
    Trials; 2021 Feb; 22(1):115. PubMed ID: 33546734
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment with tocilizumab or corticosteroids for COVID-19 patients with hyperinflammatory state: a multicentre cohort study (SAM-COVID-19).
    Rodríguez-Baño J; Pachón J; Carratalà J; Ryan P; Jarrín I; Yllescas M; Arribas JR; Berenguer J; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ;
    Clin Microbiol Infect; 2021 Feb; 27(2):244-252. PubMed ID: 32860964
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Repurposed Tocilizumab in Patients with Severe COVID-19.
    Tian J; Zhang M; Jin M; Zhang F; Chu Q; Wang X; Chen C; Yue H; Zhang L; Du R; Zhao D; Zeng Z; Zhao Y; Liu K; Wang M; Hu K; Miao X; Zhang H
    J Immunol; 2021 Feb; 206(3):599-606. PubMed ID: 33298617
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tocilizumab administration for the treatment of hospitalized patients with COVID-19: A systematic review and meta-analysis.
    Kyriakopoulos C; Ntritsos G; Gogali A; Milionis H; Evangelou E; Kostikas K
    Respirology; 2021 Nov; 26(11):1027-1040. PubMed ID: 34605114
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Towards Fixed Dosing of Tocilizumab in ICU-Admitted COVID-19 Patients: Results of an Observational Population Pharmacokinetic and Descriptive Pharmacodynamic Study.
    Moes DJAR; van Westerloo DJ; Arend SM; Swen JJ; de Vries A; Guchelaar HJ; Joosten SA; de Boer MGJ; van Gelder T; van Paassen J
    Clin Pharmacokinet; 2022 Feb; 61(2):231-247. PubMed ID: 34633645
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of tocilizumab therapy in critically ill patients with severe acute respiratory syndrome coronavirus 2.
    Saffo Z; Guo W; Springer K; Maksimowicz-McKinnon K; Kak V; McKinnon JE; Bhargava P
    J Osteopath Med; 2021 Jul; 121(8):705-714. PubMed ID: 34237804
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.